Recommended Topic Related To:

Lymphazurin

"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.

GCTB generally occurs in a"...

Lymphazurin

Side Effects
Interactions

SIDE EFFECTS

Postmarketing Experience

Hypersensitivity Reactions: Case series report an overall incidence of hypersensitivity reactions in approximately 2% of patients. Life- threatening anaphylactic reactions have occurred. Manifestations include respiratory distress, shock, angioedema, urticaria, pruritus. A death has been reported following administration of a similar compound employed to estimate the depth of a severe burn. Reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, drug reactions or previous reactions to triphenylmethane dyes [see WARNINGS and PRECAUTIONS].

Laboratory Tests: Lymphazurin (isosulfan blue) 1% interferes with measurements of oxygen saturation by pulse oximetry and of methemoglobin by gas analyzer [see WARNINGS and PRECAUTIONS].

Skin: transient or long-term (tattooing) blue coloration.

Read the Lymphazurin (isosulfan blue) Side Effects Center for a complete guide to possible side effects

DRUG INTERACTIONS

No drug interactions have been identified with Lymphazurin (isosulfan blue) 1%.

Last reviewed on RxList: 2/13/2008
This monograph has been modified to include the generic and brand name in many instances.

Side Effects
Interactions
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.